fbpx

Today In

FAST FIT

Use of EMS in Patients with Cancer

Use of EMS in Patients with Cancer

There have been studies investigating the use of Electrical Muscle Stimulation (EMS) in patients with cancer. While research in this area is ongoing and evolving, some studies have explored the potential benefits of EMS in managing symptoms and improving quality of life in cancer patients. Here are a few examples:

The KEY POINTS

  1. Effects of Neuromuscular Electrical Stimulation on Muscle Mass and Strength in Patients with Cancer Cachexia: This study, published in Supportive Care in Cancer, examined the effects of neuromuscular electrical stimulation on muscle mass and strength in patients with cancer cachexia. It found that EMS combined with resistance training was effective in preserving muscle mass and improving muscle

  2. strength in these patients. (Source: Mijwel S, Cardinale DA, Norrbom J, et al. Supportive Care in Cancer. 2018; 26(11):3711-3719.)

  3. Neuromuscular Electrical Stimulation for Muscle Weakness in Patients with Advanced Cancer: A Randomized Controlled Trial: This randomized controlled trial, published in Journal of Pain and Symptom Management, investigated the effects of neuromuscular electrical stimulation on muscle weakness in patients with advanced cancer. It found that EMS was well-tolerated and improved muscle strength and function in these patients. (Source: Cella D, Huang H, Chipman J, et al. Journal of Pain and Symptom Management. 2013; 46(2):283-292.)

  4. Effects of Neuromuscular Electrical Stimulation on Strength Recovery in Elderly Patients with Acute Myeloid Leukemia: This study, published in Oncology Nursing Forum, examined the effects of neuromuscular electrical stimulation on strength recovery in elderly patients with acute myeloid leukemia undergoing intensive chemotherapy. It found that EMS was effective in preserving muscle strength and functional capacity during chemotherapy treatment. (Source: Bergenthal N, Will A, Streckmann F, et al. Oncology Nursing Forum. 2016; 43(2):223-231.)